🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and assertions of next-day British shipping. Vendors promote the drug there before redirecting buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.

Several professionals stated the popularity for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be marketed or supplied for personal consumption under the British medical regulations.

Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Service Reaction and Material Elimination

Based on the social media company, the service has taken down violative content and banned related hashtags and query recommendations. The company said it was dedicated to maintaining the platform secure and investing in enhancing compliance measures.

Digital Marketplace Operations

Research also discovered communities with up to nine thousand members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with photos of weight loss, positive reviews and detailed instructions for preparing or administering at residence.

After minutes of entering one community, a seller shared WhatsApp details, where most purchases occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.

Item Details and Pricing

Inside these communities, messages show black plastic packages with Royal Mail stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually priced at £160 for 20mg. When questioned how long a injector should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service said it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to recent cost increases for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her team has previously seen individuals harmed by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to potentially serious health risks”.